Financial statements Vitro Art
Balance sheet data of VITRO ART
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 1 123 506,75 | 981 023,84 | 979 044,22 |
| A. Fixed assets | 868 698,28 | 875 138,68 | 593 579,24 |
| B. Current assets | 254 808,47 | 105 885,16 | 385 464,98 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 1 123 506,75 | 981 023,84 | 979 044,22 |
| A. Equity | -337 201,00 | -529 558,59 | -383 887,79 |
| B. Liabilities and provisions for liabilities | 1 460 707,75 | 1 510 582,43 | 1 362 932,01 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | 1 460 707,75 | 1 510 582,43 | 1 362 932,01 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.